Report Cover

Global Pediatric Vaccines Market Insights and Forecast to 2026


Pediatric Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Pediatric Vaccines market is segmented into
    Diphtheria
    Influenza
    Hepatitis
    Pneumococcal Diseases
    Meningococcal Diseases
    Others

Segment by Application, the Pediatric Vaccines market is segmented into
    Newborn
    Infant
    Child
    Dolescent

Regional and Country-level Analysis
The Pediatric Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pediatric Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pediatric Vaccines Market Share Analysis
Pediatric Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Vaccines business, the date to enter into the Pediatric Vaccines market, Pediatric Vaccines product introduction, recent developments, etc.

The major vendors covered:
    GlaxoSmithKline
    Merck
    Pfizer
    Sanofi
    AstraZeneca
    Novartis
    Takeda Pharmaceutical
    Bavarian Nordic
    Baxter
    LG Life Sciences
    Lupin
    S K Chemicals
    Mitsubishi Tanabe Pharma
    Janssen
    Shenzhen Kangtai Biological Products
    Sinovac Biotech
    Bharat Biotech
    Crucell
    Dynavax
    Serum Institute of India
1 Study Coverage
    1.1 Pediatric Vaccines Product Introduction
    1.2 Market Segments
    1.3 Key Pediatric Vaccines Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Pediatric Vaccines Market Size Growth Rate by Type
        1.4.2 Diphtheria
        1.4.3 Influenza
        1.4.4 Hepatitis
        1.4.5 Pneumococcal Diseases
        1.4.6 Meningococcal Diseases
        1.4.7 Others
    1.5 Market by Application
        1.5.1 Global Pediatric Vaccines Market Size Growth Rate by Application
        1.5.2 Newborn
        1.5.3 Infant
        1.5.4 Child
        1.5.5 Dolescent
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Pediatric Vaccines Market Size, Estimates and Forecasts
        2.1.1 Global Pediatric Vaccines Revenue 2015-2026
        2.1.2 Global Pediatric Vaccines Sales 2015-2026
    2.2 Global Pediatric Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
        2.2.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
        2.2.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pediatric Vaccines Competitor Landscape by Players
    3.1 Pediatric Vaccines Sales by Manufacturers
        3.1.1 Pediatric Vaccines Sales by Manufacturers (2015-2020)
        3.1.2 Pediatric Vaccines Sales Market Share by Manufacturers (2015-2020)
    3.2 Pediatric Vaccines Revenue by Manufacturers
        3.2.1 Pediatric Vaccines Revenue by Manufacturers (2015-2020)
        3.2.2 Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Pediatric Vaccines Revenue in 2019
        3.2.5 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Pediatric Vaccines Price by Manufacturers
    3.4 Pediatric Vaccines Manufacturing Base Distribution, Product Types
        3.4.1 Pediatric Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Pediatric Vaccines Product Type
        3.4.3 Date of International Manufacturers Enter into Pediatric Vaccines Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Pediatric Vaccines Market Size by Type (2015-2020)
        4.1.1 Global Pediatric Vaccines Sales by Type (2015-2020)
        4.1.2 Global Pediatric Vaccines Revenue by Type (2015-2020)
        4.1.3 Pediatric Vaccines Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Pediatric Vaccines Market Size Forecast by Type (2021-2026)
        4.2.1 Global Pediatric Vaccines Sales Forecast by Type (2021-2026)
        4.2.2 Global Pediatric Vaccines Revenue Forecast by Type (2021-2026)
        4.2.3 Pediatric Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Pediatric Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Pediatric Vaccines Market Size by Application (2015-2020)
        5.1.1 Global Pediatric Vaccines Sales by Application (2015-2020)
        5.1.2 Global Pediatric Vaccines Revenue by Application (2015-2020)
        5.1.3 Pediatric Vaccines Price by Application (2015-2020)
    5.2 Pediatric Vaccines Market Size Forecast by Application (2021-2026)
        5.2.1 Global Pediatric Vaccines Sales Forecast by Application (2021-2026)
        5.2.2 Global Pediatric Vaccines Revenue Forecast by Application (2021-2026)
        5.2.3 Global Pediatric Vaccines Price Forecast by Application (2021-2026)

6 North America
    6.1 North America Pediatric Vaccines by Country
        6.1.1 North America Pediatric Vaccines Sales by Country
        6.1.2 North America Pediatric Vaccines Revenue by Country
        6.1.3 U.S.
        6.1.4 Canada
    6.2 North America Pediatric Vaccines Market Facts & Figures by Type
    6.3 North America Pediatric Vaccines Market Facts & Figures by Application

7 Europe
    7.1 Europe Pediatric Vaccines by Country
        7.1.1 Europe Pediatric Vaccines Sales by Country
        7.1.2 Europe Pediatric Vaccines Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 U.K.
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Pediatric Vaccines Market Facts & Figures by Type
    7.3 Europe Pediatric Vaccines Market Facts & Figures by Application

8 Asia Pacific
    8.1 Asia Pacific Pediatric Vaccines by Region
        8.1.1 Asia Pacific Pediatric Vaccines Sales by Region
        8.1.2 Asia Pacific Pediatric Vaccines Revenue by Region
        8.1.3 China
        8.1.4 Japan
        8.1.5 South Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Taiwan
        8.1.9 Indonesia
        8.1.10 Thailand
        8.1.11 Malaysia
        8.1.12 Philippines
        8.1.13 Vietnam
    8.2 Asia Pacific Pediatric Vaccines Market Facts & Figures by Type
    8.3 Asia Pacific Pediatric Vaccines Market Facts & Figures by Application

9 Latin America
    9.1 Latin America Pediatric Vaccines by Country
        9.1.1 Latin America Pediatric Vaccines Sales by Country
        9.1.2 Latin America Pediatric Vaccines Revenue by Country
        9.1.3 Mexico
        9.1.4 Brazil
        9.1.5 Argentina
    9.2 Central & South America Pediatric Vaccines Market Facts & Figures by Type
    9.3 Central & South America Pediatric Vaccines Market Facts & Figures by Application

10 Middle East and Africa
    10.1 Middle East and Africa Pediatric Vaccines by Country
        10.1.1 Middle East and Africa Pediatric Vaccines Sales by Country
        10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Country
        10.1.3 Turkey
        10.1.4 Saudi Arabia
        10.1.5 U.A.E
    10.2 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Type
    10.3 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Application

11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Description and Business Overview
        11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
        11.1.5 GlaxoSmithKline Related Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Description and Business Overview
        11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
        11.2.4 Merck Pediatric Vaccines Products Offered
        11.2.5 Merck Related Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Description and Business Overview
        11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        11.3.4 Pfizer Pediatric Vaccines Products Offered
        11.3.5 Pfizer Related Developments
    11.4 Sanofi
        11.4.1 Sanofi Corporation Information
        11.4.2 Sanofi Description and Business Overview
        11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
        11.4.4 Sanofi Pediatric Vaccines Products Offered
        11.4.5 Sanofi Related Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Corporation Information
        11.5.2 AstraZeneca Description and Business Overview
        11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
        11.5.4 AstraZeneca Pediatric Vaccines Products Offered
        11.5.5 AstraZeneca Related Developments
    11.6 Novartis
        11.6.1 Novartis Corporation Information
        11.6.2 Novartis Description and Business Overview
        11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
        11.6.4 Novartis Pediatric Vaccines Products Offered
        11.6.5 Novartis Related Developments
    11.7 Takeda Pharmaceutical
        11.7.1 Takeda Pharmaceutical Corporation Information
        11.7.2 Takeda Pharmaceutical Description and Business Overview
        11.7.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
        11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
        11.7.5 Takeda Pharmaceutical Related Developments
    11.8 Bavarian Nordic
        11.8.1 Bavarian Nordic Corporation Information
        11.8.2 Bavarian Nordic Description and Business Overview
        11.8.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
        11.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
        11.8.5 Bavarian Nordic Related Developments
    11.9 Baxter
        11.9.1 Baxter Corporation Information
        11.9.2 Baxter Description and Business Overview
        11.9.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
        11.9.4 Baxter Pediatric Vaccines Products Offered
        11.9.5 Baxter Related Developments
    11.10 LG Life Sciences
        11.10.1 LG Life Sciences Corporation Information
        11.10.2 LG Life Sciences Description and Business Overview
        11.10.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
        11.10.4 LG Life Sciences Pediatric Vaccines Products Offered
        11.10.5 LG Life Sciences Related Developments
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Description and Business Overview
        11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
        11.1.5 GlaxoSmithKline Related Developments
    11.12 S K Chemicals
        11.12.1 S K Chemicals Corporation Information
        11.12.2 S K Chemicals Description and Business Overview
        11.12.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
        11.12.4 S K Chemicals Products Offered
        11.12.5 S K Chemicals Related Developments
    11.13 Mitsubishi Tanabe Pharma
        11.13.1 Mitsubishi Tanabe Pharma Corporation Information
        11.13.2 Mitsubishi Tanabe Pharma Description and Business Overview
        11.13.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
        11.13.4 Mitsubishi Tanabe Pharma Products Offered
        11.13.5 Mitsubishi Tanabe Pharma Related Developments
    11.14 Janssen
        11.14.1 Janssen Corporation Information
        11.14.2 Janssen Description and Business Overview
        11.14.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
        11.14.4 Janssen Products Offered
        11.14.5 Janssen Related Developments
    11.15 Shenzhen Kangtai Biological Products
        11.15.1 Shenzhen Kangtai Biological Products Corporation Information
        11.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
        11.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
        11.15.4 Shenzhen Kangtai Biological Products Products Offered
        11.15.5 Shenzhen Kangtai Biological Products Related Developments
    11.16 Sinovac Biotech
        11.16.1 Sinovac Biotech Corporation Information
        11.16.2 Sinovac Biotech Description and Business Overview
        11.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
        11.16.4 Sinovac Biotech Products Offered
        11.16.5 Sinovac Biotech Related Developments
    11.17 Bharat Biotech
        11.17.1 Bharat Biotech Corporation Information
        11.17.2 Bharat Biotech Description and Business Overview
        11.17.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
        11.17.4 Bharat Biotech Products Offered
        11.17.5 Bharat Biotech Related Developments
    11.18 Crucell
        11.18.1 Crucell Corporation Information
        11.18.2 Crucell Description and Business Overview
        11.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
        11.18.4 Crucell Products Offered
        11.18.5 Crucell Related Developments
    11.19 Dynavax
        11.19.1 Dynavax Corporation Information
        11.19.2 Dynavax Description and Business Overview
        11.19.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
        11.19.4 Dynavax Products Offered
        11.19.5 Dynavax Related Developments
    11.20 Serum Institute of India
        11.20.1 Serum Institute of India Corporation Information
        11.20.2 Serum Institute of India Description and Business Overview
        11.20.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
        11.20.4 Serum Institute of India Products Offered
        11.20.5 Serum Institute of India Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
    12.1 Pediatric Vaccines Market Estimates and Projections by Region
        12.1.1 Global Pediatric Vaccines Sales Forecast by Regions 2021-2026
        12.1.2 Global Pediatric Vaccines Revenue Forecast by Regions 2021-2026
    12.2 North America Pediatric Vaccines Market Size Forecast (2021-2026)
        12.2.1 North America: Pediatric Vaccines Sales Forecast (2021-2026)
        12.2.2 North America: Pediatric Vaccines Revenue Forecast (2021-2026)
        12.2.3 North America: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
    12.3 Europe Pediatric Vaccines Market Size Forecast (2021-2026)
        12.3.1 Europe: Pediatric Vaccines Sales Forecast (2021-2026)
        12.3.2 Europe: Pediatric Vaccines Revenue Forecast (2021-2026)
        12.3.3 Europe: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
    12.4 Asia Pacific Pediatric Vaccines Market Size Forecast (2021-2026)
        12.4.1 Asia Pacific: Pediatric Vaccines Sales Forecast (2021-2026)
        12.4.2 Asia Pacific: Pediatric Vaccines Revenue Forecast (2021-2026)
        12.4.3 Asia Pacific: Pediatric Vaccines Market Size Forecast by Region (2021-2026)
    12.5 Latin America Pediatric Vaccines Market Size Forecast (2021-2026)
        12.5.1 Latin America: Pediatric Vaccines Sales Forecast (2021-2026)
        12.5.2 Latin America: Pediatric Vaccines Revenue Forecast (2021-2026)
        12.5.3 Latin America: Pediatric Vaccines Market Size Forecast by Country (2021-2026)
    12.6 Middle East and Africa Pediatric Vaccines Market Size Forecast (2021-2026)
        12.6.1 Middle East and Africa: Pediatric Vaccines Sales Forecast (2021-2026)
        12.6.2 Middle East and Africa: Pediatric Vaccines Revenue Forecast (2021-2026)
        12.6.3 Middle East and Africa: Pediatric Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Pediatric Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Pediatric Vaccines Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Pediatric Vaccines Market Segments Table 2. Ranking of Global Top Pediatric Vaccines Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Pediatric Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Diphtheria Table 5. Major Manufacturers of Influenza Table 6. Major Manufacturers of Hepatitis Table 7. Major Manufacturers of Pneumococcal Diseases Table 8. Major Manufacturers of Meningococcal Diseases Table 9. Major Manufacturers of Others Table 10. Global Pediatric Vaccines Market Size Growth Rate by Application 2020-2026 (K Units) Table 11. Global Pediatric Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 12. Global Pediatric Vaccines Sales by Regions 2015-2020 (K Units) Table 13. Global Pediatric Vaccines Sales Market Share by Regions (2015-2020) Table 14. Global Pediatric Vaccines Revenue by Regions 2015-2020 (US$ Million) Table 15. Global Pediatric Vaccines Sales by Manufacturers (2015-2020) (K Units) Table 16. Global Pediatric Vaccines Sales Share by Manufacturers (2015-2020) Table 17. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Vaccines as of 2019) Table 19. Pediatric Vaccines Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Pediatric Vaccines Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Pediatric Vaccines Price (2015-2020) (USD/Unit) Table 22. Pediatric Vaccines Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Pediatric Vaccines Product Type Table 24. Date of International Manufacturers Enter into Pediatric Vaccines Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Pediatric Vaccines Sales by Type (2015-2020) (K Units) Table 27. Global Pediatric Vaccines Sales Share by Type (2015-2020) Table 28. Global Pediatric Vaccines Revenue by Type (2015-2020) (US$ Million) Table 29. Global Pediatric Vaccines Revenue Share by Type (2015-2020) Table 30. Pediatric Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 31. Global Pediatric Vaccines Sales by Application (2015-2020) (K Units) Table 32. Global Pediatric Vaccines Sales Share by Application (2015-2020) Table 33. North America Pediatric Vaccines Sales by Country (2015-2020) (K Units) Table 34. North America Pediatric Vaccines Sales Market Share by Country (2015-2020) Table 35. North America Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million) Table 36. North America Pediatric Vaccines Revenue Market Share by Country (2015-2020) Table 37. North America Pediatric Vaccines Sales by Type (2015-2020) (K Units) Table 38. North America Pediatric Vaccines Sales Market Share by Type (2015-2020) Table 39. North America Pediatric Vaccines Sales by Application (2015-2020) (K Units) Table 40. North America Pediatric Vaccines Sales Market Share by Application (2015-2020) Table 41. Europe Pediatric Vaccines Sales by Country (2015-2020) (K Units) Table 42. Europe Pediatric Vaccines Sales Market Share by Country (2015-2020) Table 43. Europe Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million) Table 44. Europe Pediatric Vaccines Revenue Market Share by Country (2015-2020) Table 45. Europe Pediatric Vaccines Sales by Type (2015-2020) (K Units) Table 46. Europe Pediatric Vaccines Sales Market Share by Type (2015-2020) Table 47. Europe Pediatric Vaccines Sales by Application (2015-2020) (K Units) Table 48. Europe Pediatric Vaccines Sales Market Share by Application (2015-2020) Table 49. Asia Pacific Pediatric Vaccines Sales by Region (2015-2020) (K Units) Table 50. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2015-2020) Table 51. Asia Pacific Pediatric Vaccines Revenue by Region (2015-2020) (US$ Million) Table 52. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2015-2020) Table 53. Asia Pacific Pediatric Vaccines Sales by Type (2015-2020) (K Units) Table 54. Asia Pacific Pediatric Vaccines Sales Market Share by Type (2015-2020) Table 55. Asia Pacific Pediatric Vaccines Sales by Application (2015-2020) (K Units) Table 56. Asia Pacific Pediatric Vaccines Sales Market Share by Application (2015-2020) Table 57. Latin America Pediatric Vaccines Sales by Country (2015-2020) (K Units) Table 58. Latin America Pediatric Vaccines Sales Market Share by Country (2015-2020) Table 59. Latin Americaa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million) Table 60. Latin America Pediatric Vaccines Revenue Market Share by Country (2015-2020) Table 61. Latin America Pediatric Vaccines Sales by Type (2015-2020) (K Units) Table 62. Latin America Pediatric Vaccines Sales Market Share by Type (2015-2020) Table 63. Latin America Pediatric Vaccines Sales by Application (2015-2020) (K Units) Table 64. Latin America Pediatric Vaccines Sales Market Share by Application (2015-2020) Table 65. Middle East and Africa Pediatric Vaccines Sales by Country (2015-2020) (K Units) Table 66. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2015-2020) Table 67. Middle East and Africa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million) Table 68. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2015-2020) Table 69. Middle East and Africa Pediatric Vaccines Sales by Type (2015-2020) (K Units) Table 70. Middle East and Africa Pediatric Vaccines Sales Market Share by Type (2015-2020) Table 71. Middle East and Africa Pediatric Vaccines Sales by Application (2015-2020) (K Units) Table 72. Middle East and Africa Pediatric Vaccines Sales Market Share by Application (2015-2020) Table 73. GlaxoSmithKline Corporation Information Table 74. GlaxoSmithKline Description and Major Businesses Table 75. GlaxoSmithKline Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. GlaxoSmithKline Product Table 77. GlaxoSmithKline Recent Development Table 78. Merck Corporation Information Table 79. Merck Description and Major Businesses Table 80. Merck Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Merck Product Table 82. Merck Recent Development Table 83. Pfizer Corporation Information Table 84. Pfizer Description and Major Businesses Table 85. Pfizer Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Pfizer Product Table 87. Pfizer Recent Development Table 88. Sanofi Corporation Information Table 89. Sanofi Description and Major Businesses Table 90. Sanofi Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Sanofi Product Table 92. Sanofi Recent Development Table 93. AstraZeneca Corporation Information Table 94. AstraZeneca Description and Major Businesses Table 95. AstraZeneca Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. AstraZeneca Product Table 97. AstraZeneca Recent Development Table 98. Novartis Corporation Information Table 99. Novartis Description and Major Businesses Table 100. Novartis Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Novartis Product Table 102. Novartis Recent Development Table 103. Takeda Pharmaceutical Corporation Information Table 104. Takeda Pharmaceutical Description and Major Businesses Table 105. Takeda Pharmaceutical Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Takeda Pharmaceutical Product Table 107. Takeda Pharmaceutical Recent Development Table 108. Bavarian Nordic Corporation Information Table 109. Bavarian Nordic Description and Major Businesses Table 110. Bavarian Nordic Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Bavarian Nordic Product Table 112. Bavarian Nordic Recent Development Table 113. Baxter Corporation Information Table 114. Baxter Description and Major Businesses Table 115. Baxter Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Baxter Product Table 117. Baxter Recent Development Table 118. LG Life Sciences Corporation Information Table 119. LG Life Sciences Description and Major Businesses Table 120. LG Life Sciences Pediatric Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. LG Life Sciences Product Table 122. LG Life Sciences Recent Development Table 123. Lupin Corporation Information Table 124. Lupin Description and Major Businesses Table 125. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. Lupin Product Table 127. Lupin Recent Development Table 128. S K Chemicals Corporation Information Table 129. S K Chemicals Description and Major Businesses Table 130. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. S K Chemicals Product Table 132. S K Chemicals Recent Development Table 133. Mitsubishi Tanabe Pharma Corporation Information Table 134. Mitsubishi Tanabe Pharma Description and Major Businesses Table 135. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. Mitsubishi Tanabe Pharma Product Table 137. Mitsubishi Tanabe Pharma Recent Development Table 138. Janssen Corporation Information Table 139. Janssen Description and Major Businesses Table 140. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 141. Janssen Product Table 142. Janssen Recent Development Table 143. Shenzhen Kangtai Biological Products Corporation Information Table 144. Shenzhen Kangtai Biological Products Description and Major Businesses Table 145. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 146. Shenzhen Kangtai Biological Products Product Table 147. Shenzhen Kangtai Biological Products Recent Development Table 148. Sinovac Biotech Corporation Information Table 149. Sinovac Biotech Description and Major Businesses Table 150. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 151. Sinovac Biotech Product Table 152. Sinovac Biotech Recent Development Table 153. Bharat Biotech Corporation Information Table 154. Bharat Biotech Description and Major Businesses Table 155. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 156. Bharat Biotech Product Table 157. Bharat Biotech Recent Development Table 158. Crucell Corporation Information Table 159. Crucell Description and Major Businesses Table 160. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 161. Crucell Product Table 162. Crucell Recent Development Table 163. Dynavax Corporation Information Table 164. Dynavax Description and Major Businesses Table 165. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 166. Dynavax Product Table 167. Dynavax Recent Development Table 168. Serum Institute of India Corporation Information Table 169. Serum Institute of India Description and Major Businesses Table 170. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 171. Serum Institute of India Product Table 172. Serum Institute of India Recent Development Table 173. Global Pediatric Vaccines Sales Forecast by Regions (2021-2026) (K Units) Table 174. Global Pediatric Vaccines Sales Market Share Forecast by Regions (2021-2026) Table 175. Global Pediatric Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million) Table 176. Global Pediatric Vaccines Revenue Market Share Forecast by Regions (2021-2026) Table 177. North America: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 178. North America: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 179. Europe: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 180. Europe: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 181. Asia Pacific: Pediatric Vaccines Sales Forecast by Region (2021-2026) (K Units) Table 182. Asia Pacific: Pediatric Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 183. Latin America: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 184. Latin America: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 185. Middle East and Africa: Pediatric Vaccines Sales Forecast by Country (2021-2026) (K Units) Table 186. Middle East and Africa: Pediatric Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 187. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 188. Key Challenges Table 189. Market Risks Table 190. Main Points Interviewed from Key Pediatric Vaccines Players Table 191. Pediatric Vaccines Customers List Table 192. Pediatric Vaccines Distributors List Table 193. Research Programs/Design for This Report Table 194. Key Data Information from Secondary Sources Table 195. Key Data Information from Primary Sources List of Figures Figure 1. Pediatric Vaccines Product Picture Figure 2. Global Pediatric Vaccines Sales Market Share by Type in 2020 & 2026 Figure 3. Diphtheria Product Picture Figure 4. Influenza Product Picture Figure 5. Hepatitis Product Picture Figure 6. Pneumococcal Diseases Product Picture Figure 7. Meningococcal Diseases Product Picture Figure 8. Others Product Picture Figure 9. Global Pediatric Vaccines Sales Market Share by Application in 2020 & 2026 Figure 10. Newborn Figure 11. Infant Figure 12. Child Figure 13. Dolescent Figure 14. Pediatric Vaccines Report Years Considered Figure 15. Global Pediatric Vaccines Market Size 2015-2026 (US$ Million) Figure 16. Global Pediatric Vaccines Sales 2015-2026 (K Units) Figure 17. Global Pediatric Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 18. Global Pediatric Vaccines Sales Market Share by Region (2015-2020) Figure 19. Global Pediatric Vaccines Sales Market Share by Region in 2019 Figure 20. Global Pediatric Vaccines Revenue Market Share by Region (2015-2020) Figure 21. Global Pediatric Vaccines Revenue Market Share by Region in 2019 Figure 22. Global Pediatric Vaccines Sales Share by Manufacturer in 2019 Figure 23. The Top 10 and 5 Players Market Share by Pediatric Vaccines Revenue in 2019 Figure 24. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 25. Global Pediatric Vaccines Sales Market Share by Type (2015-2020) Figure 26. Global Pediatric Vaccines Sales Market Share by Type in 2019 Figure 27. Global Pediatric Vaccines Revenue Market Share by Type (2015-2020) Figure 28. Global Pediatric Vaccines Revenue Market Share by Type in 2019 Figure 29. Global Pediatric Vaccines Market Share by Price Range (2015-2020) Figure 30. Global Pediatric Vaccines Sales Market Share by Application (2015-2020) Figure 31. Global Pediatric Vaccines Sales Market Share by Application in 2019 Figure 32. Global Pediatric Vaccines Revenue Market Share by Application (2015-2020) Figure 33. Global Pediatric Vaccines Revenue Market Share by Application in 2019 Figure 34. North America Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 35. North America Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 36. North America Pediatric Vaccines Sales Market Share by Country in 2019 Figure 37. North America Pediatric Vaccines Revenue Market Share by Country in 2019 Figure 38. U.S. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 39. U.S. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Canada Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 41. Canada Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. North America Pediatric Vaccines Market Share by Type in 2019 Figure 43. North America Pediatric Vaccines Market Share by Application in 2019 Figure 44. Europe Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 45. Europe Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 46. Europe Pediatric Vaccines Sales Market Share by Country in 2019 Figure 47. Europe Pediatric Vaccines Revenue Market Share by Country in 2019 Figure 48. Germany Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 49. Germany Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. France Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 51. France Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. U.K. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 53. U.K. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Italy Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 55. Italy Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Russia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 57. Russia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Europe Pediatric Vaccines Market Share by Type in 2019 Figure 59. Europe Pediatric Vaccines Market Share by Application in 2019 Figure 60. Asia Pacific Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 61. Asia Pacific Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 62. Asia Pacific Pediatric Vaccines Sales Market Share by Region in 2019 Figure 63. Asia Pacific Pediatric Vaccines Revenue Market Share by Region in 2019 Figure 64. China Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 65. China Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Japan Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 67. Japan Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. South Korea Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 69. South Korea Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. India Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 71. India Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Australia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 73. Australia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Taiwan Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 75. Taiwan Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Indonesia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 77. Indonesia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Thailand Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 79. Thailand Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Malaysia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 81. Malaysia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Philippines Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 83. Philippines Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Vietnam Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 85. Vietnam Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Asia Pacific Pediatric Vaccines Market Share by Type in 2019 Figure 87. Asia Pacific Pediatric Vaccines Market Share by Application in 2019 Figure 88. Latin America Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 89. Latin America Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 90. Latin America Pediatric Vaccines Sales Market Share by Country in 2019 Figure 91. Latin America Pediatric Vaccines Revenue Market Share by Country in 2019 Figure 92. Mexico Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 93. Mexico Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Brazil Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 95. Brazil Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Argentina Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 97. Argentina Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Latin America Pediatric Vaccines Market Share by Type in 2019 Figure 99. Latin America Pediatric Vaccines Market Share by Application in 2019 Figure 100. Middle East and Africa Pediatric Vaccines Sales Growth Rate 2015-2020 (K Units) Figure 101. Middle East and Africa Pediatric Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 102. Middle East and Africa Pediatric Vaccines Sales Market Share by Country in 2019 Figure 103. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country in 2019 Figure 104. Turkey Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 105. Turkey Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Saudi Arabia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 107. Saudi Arabia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. U.A.E Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 109. U.A.E Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 110. Middle East and Africa Pediatric Vaccines Market Share by Type in 2019 Figure 111. Middle East and Africa Pediatric Vaccines Market Share by Application in 2019 Figure 112. North America Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 113. North America Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Europe Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. Europe Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Asia Pacific Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. Asia Pacific Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Latin America Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. Latin America Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Middle East and Africa Pediatric Vaccines Sales Growth Rate Forecast (2021-2026) (K Units) Figure 121. Middle East and Africa Pediatric Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 122. Porter's Five Forces Analysis Figure 123. Channels of Distribution Figure 124. Distributors Profiles Figure 125. Bottom-up and Top-down Approaches for This Report Figure 126. Data Triangulation Figure 127. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

United States Alvimopan (CAS 156053-89-3) Market Insights and Forecast to 2026

Market Analysis and Insights: United States Alvimopan (CAS 156053-89-3) Market In 2019, the United States Alvimopan (CAS 156053-89-3) market size was US$ 3.59 million and it is expected to reach US$ 4.74 million by the end of 2026, with a CAGR of 5.5...

North America Induction Furnace (IF) Market Insights and Forecast to 2026

Induction furnace is an electrical furnace that facilitates melting of metal using induction heating. It is an energy-efficient and easily-controlled melting process, based on the heating effect of the electromagnetic field. A typical induction furna...

Global Vacuum Induction Melting Furnace (VIM) Market Research Report 2020

Market Analysis and Insights: Global Vacuum Induction Melting Furnace (VIM) Market The market for Vacuum Induction Melting Furnace (VIM) was anticipated to grow from US$ 96.58 million in 2020 to US$ 119.08 million by 2026; it is expected to grow at a...

Global Thermoplastic Butterfly Valves Sales Market Report 2020

Market Analysis and Insights: Global Thermoplastic Butterfly Valves Market The global Thermoplastic Butterfly Valves market was valued at US$ 191.74 million in 2020 and will reach US$ 246.47 million by the end of 2026, growing at a CAGR of 4.27% duri...

Global Television (TV) Mounts Market Insights, Forecast to 2026

Market Analysis and Insights: Global Television (TV) Mounts Market Global Television (TV) Mounts market is estimated at USD 2017.26 million in 2019 and is expected to reach USD 1995.28 million by 2026, at a CAGR of -0.35% between 2019 and 2025. Globa...

Publisher: QY Research
Chat with us